Haem catabolism: A novel modulator of inflammation in Gilbert's syndrome

European Journal of Clinical Investigation

Volumn 43, Issue 9, 2013, Pages 912-919

  Wallner, Marlies ^a   Bulmer, Andrew C ^b   Mölzer, Christine ^a   Müllner, Elisabeth ^a   Marculescu, Rodrig ^c   Doberer, Daniel ^c   Wolzt, Michael ^c   Wagner, Oswald F ^c   Wagner, Karl Heinz ^a,b  

^a UNIVERSITY OF VIENNA   (Austria)

^b GRIFFITH UNIVERSITY   (Australia)

^c MEDICAL UNIVERSITY OF VIENNA   (Austria)

Author keywords

Cytokines; Gilbert's syndrome; Haem oxygenase; Metabolic syndrome; Obesity; Unconjugated bilirubin

Indexed keywords

BILIRUBIN; C REACTIVE PROTEIN; CARBOXYHEMOGLOBIN; HEME; HEME OXYGENASE; INTERLEUKIN 1BETA; INTERLEUKIN 6; IRON; TUMOR NECROSIS FACTOR ALPHA;

ADULT; ARTICLE; BODY MASS; CATABOLISM; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GILBERT DISEASE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; INFLAMMATION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL;

CYTOKINES; GILBERT'S SYNDROME; HAEM OXYGENASE; METABOLIC SYNDROME; OBESITY; UNCONJUGATED BILIRUBIN;

ADULT; AGED; AGED, 80 AND OVER; BILIRUBIN; C-REACTIVE PROTEIN; CARBOXYHEMOGLOBIN; CASE-CONTROL STUDIES; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; GILBERT DISEASE; HEME; HEME OXYGENASE (DECYCLIZING); HUMANS; INTERLEUKIN-1BETA; INTERLEUKIN-6; MALE; MIDDLE AGED; TUMOR NECROSIS FACTOR-ALPHA; YOUNG ADULT;

EID: 84881664404     PISSN: 00142972     EISSN: 13652362     Source Type: Journal    
DOI: 10.1111/eci.12120     Document Type: Article

References (41)

1. Vitek L, Ostrow JD. Bilirubin chemistry and metabolism; harmful and protective aspects. Curr Pharm Des 2009;15:2869-83.
2. Bosma PJ, Chowdhury JR, Bakker C, Gantla S, de Boer A, Oostra BA et al. The genetic basis of the reduced expression of bilirubin UDP-glucuronosyltransferase 1 in Gilbert's syndrome. N Engl J Med 1995;333:1171-5.
3. Bosma PJ. Inherited disorders of bilirubin metabolism. J Hepatol 2003;38:107-17.
4. Fertrin KY, Goncalves MS, Saad STCosta FF. Frequencies of UDP-glucuronosyltransferase 1 (UGT1A1) gene promoter polymorphisms among distinct ethnic groups from Brazil. Am J Med Genet 2002;108:117-9.
5. Lin JP, Vitek L, Schwertner HA. Serum bilirubin and genes controlling bilirubin concentrations as biomarkers for cardiovascular disease. Clin Chem 2010;56:1535-43.
6. Schwertner HA, Jackson WG, Tolan G. Association of low serum concentration of bilirubin with increased risk of coronary artery disease. Clin Chem 1994;40:18-23.
7. Breimer LH, Wannamethee G, Ebrahim S, Shaper AG. Serum bilirubin and risk of ischemic heart disease in middle-aged British men. Clin Chem 1995;41:1504-8.
8. Hwang HJ, Lee SW, Kim SH. Relationship between bilirubin and C-reactive protein. Clin Chem Lab Med 2011;49:1823-8.
9. Bulmer AC, Blanchfield JT, Toth I, Fassett RG, Coombes JS. Improved resistance to serum oxidation in Gilbert's syndrome: a mechanism for cardiovascular protection. Atherosclerosis 2008;199:390-6.
10. Bulmer AC, Verkade HJ, Wagner KH. Bilirubin and beyond: a review of lipid status in Gilbert's syndrome and its relevance to cardiovascular disease protection. Prog Lipid Res 2013;52:193-205.
11. Vitek L, Jirsa M, Brodanova M, Kalab M, Marecek Z, Danzig V et al. Gilbert syndrome and ischemic heart disease: A protective effect of elevated bilirubin levels. Atherosclerosis 2002;160:449-56.
12. de Vries HS, Te Morsche RHM, Jenniskens K, Peters WHM, de Jong DJ. A functional polymorphism in UGT1A1 related to hyperbilirubinemia is associated with a decreased risk for Crohn's disease. J Crohns Colitis 2011;6:597-602.
13. Bach FH. Heme oxygenase-1: a therapeutic amplification funnel. FASEB J 2005;19:1216-9.
14. Hayashi S, Takamiya R, Yamaguchi T, Matsumoto K, Tojo SJ, Tamatani T et al. Induction of heme oxygenase-1 suppresses venular leukocyte adhesion elicited by oxidative stress: role of bilirubin generated by the enzyme. Circ Res 1999;85:663-71.
15. Kato Y, Shimazu M, Kondo M, Uchida K, Kumamoto Y, Wakabayashi G et al. Bilirubin rinse: a simple protectant against the rat liver graft injury mimicking heme oxygenase-1 preconditioning. Hepatology 2003;38:364-73.
16. Furchgott RF, Jothianandan D. Endothelium-dependent and -independent vasodilation involving cyclic GMP: relaxation induced by nitric oxide, carbon monoxide and light. Blood Vessels 1991;28:52-61.
17. Pamplona A, Ferreira A, Balla J, Jeney V, Balla G, Epiphanio S et al. Heme oxygenase-1 and carbon monoxide suppress the pathogenesis of experimental cerebral malaria. Nat Med 2007;13:703-10.
18. Morse D, Pischke SE, Zhou Z, Davis RJ, Flavell RA, Loop T et al. Suppression of inflammatory cytokine production by carbon monoxide involves the JNK pathway and AP-1. J Biol Chem 2003;278:-8.
19. Kim KM, Pae HO, Zheng M, Park R, Kim YM, Chung HT. Carbon monoxide induces heme oxygenase-1 via activation of protein kinase R-like endoplasmic reticulum kinase and inhibits endothelial cell apoptosis triggered by endoplasmic reticulum stress. Circ Res 2007;101:919-27.
20. Pradhan AD, Manson JE, Rifai N, Buring JE, Ridker PM. C-reactive protein, interleukin 6, and risk of developing type 2 diabetes mellitus. JAMA 2001;286:327-34.
21. Tapan S, Karadurmus N, Dogru T, Ercin CN, Tasci I, Bilgi C et al. Decreased small dense LDL levels in Gilbert's syndrome. Clin Biochem 2011;44:300-3.
22. Bermudez EA, Rifai N, Buring J, Manson JE, Ridker PM. Interrelationships among circulating interleukin-6, C-reactive protein, and traditional cardiovascular risk factors in women. Arterioscler Thromb Vasc Biol 2002;22:1668-73.
23. Boon AC, Hawkins CL, Bisht K, Coombes JS, Bakrania B, Wagner KH et al. Reduced circulating oxidized LDL is associated with hypocholesterolemia and enhanced thiol status in Gilbert syndrome. Free Radic Biol Med 2012;52:2120-7.
24. Brower JO, Lightner DA, McDonagh AF. Aromatic congeners of bilirubin: synthesis, stereochemistry, glucuronidation and hepatic transport. Tetrahedron 2001;57:7813-27.
25. Brito MA, Silva RF, Brites D. Bilirubin toxicity to human erythrocytes: a review. Clin Chim Acta 2006;374:46-56.
26. Bulmer AC, Blanchfield JT, Coombes JS, Toth I. In vitro permeability and metabolic stability of bile pigments and the effects of hydrophilic and lipophilic modification of biliverdin. Bioorg Med Chem 2008;16:3616-25.
27. Weinberger B, Archer FE, Kathiravan S, Hirsch DS, Kleinfeld AM, Vetrano AM et al. Effects of bilirubin on neutrophil responses in newborn infants. Neonatology 2012;103:105-11.
28. Motterlini R, Otterbein LE. The therapeutic potential of carbon monoxide. Nat Rev Drug Discov 2010;9:728-43.
29. Gross O, Thomas CJ, Guarda G, Tschopp J. The inflammasome: an integrated view. Immunol Rev 2011;243:136-51.
30. Bedard K, Krause KH. The NOX family of ROS-generating NADPH oxidases: physiology and pathophysiology. Physiol Rev 2007;87:245-313.
31. Keshavan P, Schwemberger SJ, Smith DL, Babcock GF, Zucker SD. Unconjugated bilirubin induces apoptosis in colon cancer cells by triggering mitochondrial depolarization. Int J Cancer 2004;112:433-45.
32. Rodrigues CM, Sola S, Brites D. Bilirubin induces apoptosis via the mitochondrial pathway in developing rat brain neurons. Hepatology 2002;35:1186-95.
33. Li P, Elrayess MA, Gomma AH, Palmen J, Hawe E, Fox KM et al. The microsatellite polymorphism of heme oxygenase-1 is associated with baseline plasma IL-6 level but not with restenosis after coronary in-stenting. Chin Med J (Engl) 2005;118:1525-32.
34. D'Silva S, Borse V, Colah RB, Ghosh K, Mukherjee MB. Association of (GT)n repeats promoter polymorphism of heme oxygenase-1 gene with serum bilirubin levels in healthy Indian adults. Genet Test Mol Biomarkers 2011;15:215-8.
35. Immenschuh S, Shan Y, Kroll H, Santoso S, Wossmann W, Bein G et al. Marked hyperbilirubinemia associated with the heme oxygenase-1 gene promoter microsatellite polymorphism in a boy with autoimmune hemolytic anemia. Pediatrics 2007;119:e764-7.
36. Albert MA. The role of C-reactive protein in cardiovascular disease risk. Curr Cardiol Rep 2000;2:274-9.
37. Kwon KM, Kam JH, Kim MY, Chung CH, Kim JK, Linton JA et al. Inverse association between total bilirubin and metabolic syndrome in rural korean women. J Womens Health (Larchmt) 2011;20:963-9.
38. Castell JV, Gomez-Lechon MJ, David M, Fabra R, Trullenque R, Heinrich PC. Acute-phase response of human hepatocytes: regulation of acute-phase protein synthesis by interleukin-6. Hepatology 1990;12:1179-86.
39. Wallner M, Marculescu R, Doberer D, Wolzt M, Wagner O, Vitek L et al. Protection from age-related increase in lipid biomarkers and inflammation contributes to cardiovascular protection in Gilbert's syndrome. Clin Sci (Lond) 2013;125:257-64.
40. Park HS, Park JY, Yu R. Relationship of obesity and visceral adiposity with serum concentrations of CRP, TNF-alpha and IL-6. Diabetes Res Clin Pract 2005;69:29-35.
41. Bulmer AC, Coombes JS, Blanchfield JT, Toth I, Fassett RG, Taylor SM. Bile pigment pharmacokinetics and absorption in the rat: therapeutic potential for enteral administration. Br J Pharmacol 2011;164:1857-70.